Ceritinib (Zykadia)

[ ANTI-CANCER DRUGS ]
UNIT PRICE: 4,599.00 USD
  4,599.00 USD
In Stock

Ceritinib (trade name Zykadia)

Related Products

Product Details

Prescription-only drug used for the treatment non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014. It is available as a 150 mg capsule with a one-time daily dosing requirement of 750 mg for NSCLC
VIEW ALL PRODUCTS